[HTML][HTML] Anti-trypanosomatid drug discovery: progress and challenges
Leishmaniasis (visceral and cutaneous), Chagas disease and human African
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
Anti-trypanosomatid drug discovery: progress and challenges
M De Rycker, S Wyllie, D Horn… - Nature Reviews …, 2023 - discovery.dundee.ac.uk
Leishmaniasis (visceral and cutaneous), Chagas disease and human African
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
[HTML][HTML] Anti-trypanosomatid drug discovery: progress and challenges
M De Rycker, S Wyllie, D Horn, KD Read… - Nature Reviews …, 2023 - ncbi.nlm.nih.gov
Leishmaniasis (visceral and cutaneous), Chagas disease and human African
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
Anti-trypanosomatid drug discovery: progress and challenges.
M De Rycker, S Wyllie, D Horn, KD Read… - Nature reviews …, 2022 - europepmc.org
Leishmaniasis (visceral and cutaneous), Chagas disease and human African
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
[PDF][PDF] Anti-trypanosomatid drug discovery: progress and challenges
M De Rycker, S Wyllie, D Horn, KD Read… - naTure revIeWS …, 2023 - scienovate.com
Leishmaniasis (visceral and cutaneous), Chagas disease and human African
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
Anti-trypanosomatid drug discovery: progress and challenges.
M de Rycker, S Wyllie, D Horn, KD Read, IH Gilbert - 2022 - cabidigitallibrary.org
Leishmaniasis (visceral and cutaneous), Chagas disease and human African
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
Anti-trypanosomatid drug discovery: progress and challenges
M De Rycker, S Wyllie, D Horn… - Nature reviews …, 2023 - pubmed.ncbi.nlm.nih.gov
Leishmaniasis (visceral and cutaneous), Chagas disease and human African
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …
trypanosomiasis cause substantial death and morbidity, particularly in low-and middle …